Purple Biotech Ltd - ADR

NASDAQ:PPBT  
1.03
-0.08 (-7.21%)
7:59:53 PM EDT: $1.14 +0.11 (+10.68%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Purple Biotech Ltd - ADR Stock, NASDAQ:PPBT

Science Park, 4 Oppenheimer Street, Rehovot, Tel Aviv 7670104
Israel
Phone: +972.3.933.3121
Number of Employees: 20

Description

Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. It operates through two segments: Oncology, and Pain & Hypertension. The Oncology segment includes NT219, a therapeutic candidate which is a small molecule that targets two signal transduction pathways which are involved in the development of cancer drug resistance mechanisms, and which is currently in the late pre-clinical stage of development. The Pain & Hypertension segment includes Consensi, a combination drug for the simultaneous treatment of two clinical conditions, pain caused by osteoarthritis and hypertension (high blood pressure), which can be pre-existing or caused by the treatment for osteoarthritis. The company was founded by John Paul Waymack on August 12, 1968 and is headquartered in Rehovot, Israel.